{"id":"ameluz","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Erythema","drugRate":"92%","severity":"common","organSystem":""},{"effect":"Pain/Burning","drugRate":"92%","severity":"common","organSystem":""},{"effect":"Irritation","drugRate":"72%","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"35%","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"34%","severity":"common","organSystem":""},{"effect":"Exfoliation","drugRate":"19%","severity":"common","organSystem":""},{"effect":"Scab","drugRate":"19%","severity":"common","organSystem":""},{"effect":"Induration","drugRate":"12%","severity":"common","organSystem":""},{"effect":"Vesicles","drugRate":"12%","severity":"common","organSystem":""},{"effect":"Paresthesia","drugRate":"9%","severity":"common","organSystem":""},{"effect":"Hyperalgesia","drugRate":"6%","severity":"common","organSystem":""},{"effect":"Reaction Discomfort","drugRate":"4%","severity":"common","organSystem":""},{"effect":"Erosion","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Discharge","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Bleeding","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Pustules","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Chills","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Eyelid Edema","drugRate":"1%","severity":"common","organSystem":""}],"contraindications":["Photosensitivity"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Allergic Contact Dermatitis","drugRate":"6%","severity":"serious"},{"effect":"Severe Pain/Burning","drugRate":"30%","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"650daa9f-aeec-49ce-95b9-5fa20b988afd","title":"AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE) GEL [BIOFRONTERA INC.]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-27T23:42:22.459Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Actinic keratosis","diseaseId":"actinic-keratosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Fluorescent stain","diseaseId":"fluorescent-stain","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Non-Hyperkeratotic Actinic Keratoses","diseaseId":"non-hyperkeratotic-actinic-keratoses","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06876038","phase":"PHASE2","title":"Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Boston","startDate":"2026-09","conditions":"Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia","enrollment":65},{"nctId":"NCT07225621","phase":"PHASE2","title":"Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Alpheus Medical, Inc.","startDate":"2026-01-28","conditions":"Glioblastoma, GBM","enrollment":103},{"nctId":"NCT07241585","phase":"NA","title":"Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2026-05-01","conditions":"Nonmelanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma","enrollment":54},{"nctId":"NCT06417281","phase":"PHASE3","title":"Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2024-06-19","conditions":"5-aminolevulinic Acid, Malignant Glioma of Brain","enrollment":86},{"nctId":"NCT07144345","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-19","conditions":"Actinic Keratosis","enrollment":160},{"nctId":"NCT06665724","phase":"PHASE1","title":"Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2025-01-27","conditions":"Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Glioblastoma (GBM)","enrollment":16},{"nctId":"NCT07038278","phase":"EARLY_PHASE1","title":"5-AminoLevulinic Acid Aided Resection Margins in Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-04-01","conditions":"Soft Tissue Sarcoma (STS)","enrollment":20},{"nctId":"NCT07076472","phase":"EARLY_PHASE1","title":"Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-14","conditions":"Progressive Glioblastoma, Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT07144852","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-29","conditions":"Actinic Keratosis","enrollment":260},{"nctId":"NCT05923060","phase":"PHASE2","title":"Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2024-08-25","conditions":"Actinic Keratoses","enrollment":14},{"nctId":"NCT07420543","phase":"","title":"Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach","status":"RECRUITING","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2017-01-18","conditions":"Brain Tumors and/or Solid Tumors Including, Glioblastoma, Glioblastoma (GBM)","enrollment":30},{"nctId":"NCT05662202","phase":"PHASE3","title":"Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2022-12-12","conditions":"Actinic Keratoses","enrollment":172},{"nctId":"NCT06307548","phase":"PHASE1, PHASE2","title":"Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-07-30","conditions":"Locally Advanced Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Stage III Colorectal Cancer","enrollment":21},{"nctId":"NCT07201376","phase":"","title":"Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2025-11-14","conditions":"Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth","enrollment":125},{"nctId":"NCT03048240","phase":"NA","title":"INtraoperative photoDYnamic Therapy of GliOblastoma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2017-05-05","conditions":"Glioblastoma","enrollment":10},{"nctId":"NCT06777511","phase":"","title":"Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients","status":"NOT_YET_RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2026-03-01","conditions":"Amputation, Osseointegration","enrollment":10},{"nctId":"NCT07381972","phase":"PHASE3","title":"Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-11-24","conditions":"Nodular Basal Cell Carcinoma of Skin","enrollment":142},{"nctId":"NCT06623201","phase":"PHASE1","title":"Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas","status":"RECRUITING","sponsor":"Nathalie Zeitouni","startDate":"2024-10-07","conditions":"Basal Cell Carcinoma (BCC)","enrollment":20},{"nctId":"NCT04923516","phase":"","title":"Prevalence of Acute Hepatic Porphyria","status":"COMPLETED","sponsor":"Association pour la Recherche en Medecine Interne","startDate":"2021-08-23","conditions":"Acute Hepatic Porphyria","enrollment":150},{"nctId":"NCT07366892","phase":"","title":"Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use","status":"NOT_YET_RECRUITING","sponsor":"Leica Microsystems (Schweiz) AG","startDate":"2026-02-01","conditions":"Suspected Grade III and IV Gliomas Requiring Surgical Intervention, Neurosurgical Procedure, Glioma","enrollment":37},{"nctId":"NCT06907485","phase":"PHASE2","title":"A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients","status":"NOT_YET_RECRUITING","sponsor":"Costas Hadjipanayis","startDate":"2026-08","conditions":"Pediatric Brain Tumor","enrollment":20},{"nctId":"NCT01561157","phase":"","title":"Longitudinal Study of the Porphyrias","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2010-11-01","conditions":"Acute Porphyrias, Cutaneous Porphyrias","enrollment":1500},{"nctId":"NCT03573401","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2018-09-25","conditions":"Superficial Basal Cell Carcinoma","enrollment":187},{"nctId":"NCT07053852","phase":"PHASE1","title":"Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage","status":"COMPLETED","sponsor":"Sherrif Ibrahim","startDate":"2025-06-27","conditions":"Actinic Keratoses, Photodamage","enrollment":10},{"nctId":"NCT05962541","phase":"PHASE4","title":"Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)","status":"RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2025-12-22","conditions":"Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma","enrollment":327},{"nctId":"NCT07306247","phase":"NA","title":"Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-01","conditions":"HPV-16/18, Photodynamic Therapy (PDT), LSIL, Low Grade Squamous Intraepithelial Lesion","enrollment":225},{"nctId":"NCT05080764","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2021-12-10","conditions":"Acne Vulgaris","enrollment":126},{"nctId":"NCT07290959","phase":"NA","title":"Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK","status":"COMPLETED","sponsor":"San Salvatore Hospital of L'Aquila","startDate":"2025-01-02","conditions":"Actinic Keratosis (AK)","enrollment":55},{"nctId":"NCT02660645","phase":"","title":"Blue Light Cystoscopy With Cysview® Registry","status":"RECRUITING","sponsor":"Photocure","startDate":"2014-04","conditions":"Bladder Cancer","enrollment":4400},{"nctId":"NCT07286903","phase":"","title":"Fluorescence Enhanced Stereotactic Surgery (FESS)","status":"RECRUITING","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2024-07-01","conditions":"High Grade Glioma, High Grade Glioma (III or IV)","enrollment":20},{"nctId":"NCT04738162","phase":"PHASE2","title":"Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2020-09-25","conditions":"Brain Tumor, Pediatric","enrollment":78},{"nctId":"NCT04391062","phase":"PHASE2","title":"Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2021-09-28","conditions":"Glioblastoma","enrollment":14},{"nctId":"NCT05020912","phase":"PHASE2","title":"Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2021-12-13","conditions":"Basal Cell Carcinoma","enrollment":28},{"nctId":"NCT07075328","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma","status":"RECRUITING","sponsor":"Otsuka Medical Devices Co., Ltd. Japan","startDate":"2024-04-01","conditions":"Adult T-Cell Leukemia/Lymphoma (ATLL)","enrollment":49},{"nctId":"NCT04223570","phase":"","title":"Portable Measurement of Protoporphyrin IX in the Skin","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2022-12-01","conditions":"Photodynamic Therapy, Protoporphyrin IX","enrollment":219},{"nctId":"NCT07164053","phase":"","title":"Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes.","status":"NOT_YET_RECRUITING","sponsor":"Leica Microsystems (Schweiz) AG","startDate":"2025-12-25","conditions":"High-Grade Glioma (WHO III-IV), Cerebral Vascular Conditions Requiring Surgical Intervention, Conditions Requiring Plastic and Reconstructive Surgery","enrollment":32},{"nctId":"NCT06525571","phase":"PHASE3","title":"Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-12-20","conditions":"Bladder Cancer","enrollment":200},{"nctId":"NCT07111182","phase":"NA","title":"Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-10-27","conditions":"Brain Neoplasms","enrollment":8},{"nctId":"NCT04381806","phase":"PHASE1","title":"Phase I Study in Advanced Malignancies With 5-ALA","status":"SUSPENDED","sponsor":"Fox Chase Cancer Center","startDate":"2020-07-30","conditions":"Solid Tumor","enrollment":130},{"nctId":"NCT06027619","phase":"PHASE2","title":"Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-10-02","conditions":"Actinic Keratosis","enrollment":30},{"nctId":"NCT05804370","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)","status":"RECRUITING","sponsor":"NX Development Corp","startDate":"2024-05-30","conditions":"Ovarian Cancer","enrollment":170},{"nctId":"NCT04400539","phase":"PHASE2","title":"The IMmunotherapy Pleural 5-ALA PDT","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2022-05-09","conditions":"Mesotheliomas Pleural, Malignant Pleural Mesothelioma","enrollment":20},{"nctId":"NCT01811121","phase":"PHASE3","title":"MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2013-02","conditions":"Glioblastoma","enrollment":170},{"nctId":"NCT02191488","phase":"PHASE1","title":"ALA-induced PpIX Fluorescence During Brain Tumor Resection","status":"ACTIVE_NOT_RECRUITING","sponsor":"David W. Roberts","startDate":"2014-07","conditions":"Brain Tumors","enrollment":540},{"nctId":"NCT05736406","phase":"PHASE1, PHASE2","title":"A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma","status":"RECRUITING","sponsor":"Hemerion Therapeutics","startDate":"2024-02-20","conditions":"Primary Glioblastoma","enrollment":12},{"nctId":"NCT04815083","phase":"PHASE3","title":"Fluorescence Imaging of Carcinoma During Breast Conserving Surgery","status":"TERMINATED","sponsor":"SBI ALApharma Canada, Inc.","startDate":"2021-04-27","conditions":"Breast Neoplasm Female, Breast Cancer","enrollment":57},{"nctId":"NCT06455189","phase":"PHASE1","title":"Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-12","conditions":"Glioblastoma, Brain Tumor","enrollment":114},{"nctId":"NCT02691923","phase":"PHASE2","title":"Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker","status":"RECRUITING","sponsor":"David W. Roberts","startDate":"2016-03","conditions":"Brain Cancer","enrollment":30},{"nctId":"NCT02373371","phase":"PHASE3","title":"Actinic Keratoses Treatment With Metvix® in Combination With Light","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2015-03-25","conditions":"Actinic Keratoses","enrollment":26},{"nctId":"NCT05101798","phase":"PHASE2","title":"The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2021-09-14","conditions":"Neoplasm, Skull Base Neoplasm","enrollment":7},{"nctId":"NCT05104099","phase":"PHASE2","title":"Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia","status":"COMPLETED","sponsor":"Institut de Cancérologie de Lorraine","startDate":"2021-11-29","conditions":"Vulvar Intraepithelial Neoplasia, Vulvar High Grade Squamous Intraepithelial Lesion, Differentiated Vulvar Intraepithelial Neoplasia","enrollment":17},{"nctId":"NCT04780009","phase":"","title":"Loupe-Based Intraoperative Fluorescence Imaging","status":"RECRUITING","sponsor":"Guoqiang Yu","startDate":"2017-11-17","conditions":"Glioblastoma Multiforme, Anaplastic Astrocytoma","enrollment":30},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":"Cardiac Surgical Procedures, Coronary Artery Bypass, Aortic Valve Disease","enrollment":48},{"nctId":"NCT05362409","phase":"PHASE1","title":"Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma","status":"COMPLETED","sponsor":"Alpheus Medical, Inc.","startDate":"2022-06-29","conditions":"High Grade Glioma","enrollment":22},{"nctId":"NCT05474573","phase":"NA","title":"Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases","status":"RECRUITING","sponsor":"Sklifosovsky Institute of Emergency Care","startDate":"2022-09-01","conditions":"Glioma, Malignant, Metastases to Brain","enrollment":52},{"nctId":"NCT05475522","phase":"NA","title":"Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases","status":"SUSPENDED","sponsor":"Sklifosovsky Institute of Emergency Care","startDate":"2022-09-01","conditions":"Gliomas, Malignant, Metastases to Brain","enrollment":134},{"nctId":"NCT03897491","phase":"PHASE2","title":"PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"photonamic GmbH & Co. KG","startDate":"2021-09-03","conditions":"Glioblastoma","enrollment":20},{"nctId":"NCT06160492","phase":"PHASE3","title":"Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)","status":"RECRUITING","sponsor":"Lee's Pharmaceutical Limited","startDate":"2025-04-14","conditions":"5-aminolevulinic Acid, Fluorescence-guided Resection","enrollment":144},{"nctId":"NCT06052033","phase":"NA","title":"Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2023-09-11","conditions":"HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection","enrollment":40},{"nctId":"NCT04429308","phase":"PHASE2","title":"PDT vs Peels for Treatment of Actinic Keratoses","status":"NOT_YET_RECRUITING","sponsor":"Northwestern University","startDate":"2025-08","conditions":"Actinic Keratoses","enrollment":60},{"nctId":"NCT02728388","phase":"PHASE2","title":"Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II","status":"RECRUITING","sponsor":"Donald Basel","startDate":"2016-08","conditions":"NEUROFIBROMATOSIS 1","enrollment":30},{"nctId":"NCT03909646","phase":"PHASE4","title":"Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2019-05-27","conditions":"Bowen's Disease","enrollment":250},{"nctId":"NCT06948552","phase":"PHASE2","title":"Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA","status":"NOT_YET_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2025-05","conditions":"Upper Tract Urothelial Carcinoma","enrollment":10},{"nctId":"NCT04552990","phase":"PHASE2","title":"Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-09-09","conditions":"BCC, BCC - Basal Cell Carcinoma, Basal Cell Carcinoma","enrollment":16},{"nctId":"NCT00472459","phase":"PHASE3","title":"Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2003-07-25","conditions":"Actinic Keratosis, Warts, Basal Cell Carcinoma","enrollment":82},{"nctId":"NCT06678867","phase":"PHASE2","title":"The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours","status":"NOT_YET_RECRUITING","sponsor":"University College, London","startDate":"2025-03-25","conditions":"Brain Tumor","enrollment":80},{"nctId":"NCT04559685","phase":"EARLY_PHASE1","title":"Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma","status":"RECRUITING","sponsor":"Nader Sanai","startDate":"2021-03-15","conditions":"High Grade Glioma","enrollment":30},{"nctId":"NCT04469699","phase":"PHASE2","title":"Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma","status":"TERMINATED","sponsor":"University Hospital Muenster","startDate":"2021-04-12","conditions":"Glioblastoma Multiforme, Adult","enrollment":30},{"nctId":"NCT01689935","phase":"PHASE1","title":"Reduced Side-Effects of Photodynamic Therapy for the Treatment of Moderate to Severe Acne (i-PDT)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-11-01","conditions":"Acne Vulgaris","enrollment":35},{"nctId":"NCT06159842","phase":"PHASE2","title":"Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)","status":"COMPLETED","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2023-08-08","conditions":"Facial Cutaneous Squamous Cell Carcinoma in Situ","enrollment":32},{"nctId":"NCT03066843","phase":"NA","title":"Photodynamic Therapy Incubation Times for Actinic Keratosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-03-01","conditions":"Actinic Keratoses","enrollment":60},{"nctId":"NCT06745999","phase":"PHASE4","title":"Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face","status":"RECRUITING","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2023-05-03","conditions":"Actinic Keratoses","enrollment":40},{"nctId":"NCT06740097","phase":"NA","title":"Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery","status":"RECRUITING","sponsor":"Kuopio University Hospital","startDate":"2024-09-30","conditions":"High Grade Gliomas","enrollment":50},{"nctId":"NCT06736470","phase":"","title":"Surgical Suction Aspirates Fluorescence Measurement","status":"RECRUITING","sponsor":"Kuopio University Hospital","startDate":"2023-02-07","conditions":"Gliomas, High-grade Glioma","enrollment":25},{"nctId":"NCT05590689","phase":"PHASE1, PHASE2","title":"Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor","status":"RECRUITING","sponsor":"Universität Münster","startDate":"2022-11-09","conditions":"Glioblastoma","enrollment":34},{"nctId":"NCT06039709","phase":"PHASE1","title":"Sonodynamic Therapy in Patients With Recurrent GBM","status":"RECRUITING","sponsor":"Shayan Moosa, MD","startDate":"2024-01-31","conditions":"Recurrent Glioblastoma, Glioblastoma Multiforme, GBM","enrollment":11},{"nctId":"NCT04845919","phase":"PHASE2","title":"Sonodynamic Therapy with ExAblate System in Glioblastoma Patients","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2023-02-22","conditions":"Glioblastoma Multiforme","enrollment":5},{"nctId":"NCT06679712","phase":"NA","title":"Transbroncheal Novel PDT Peripheral Lung Tumor Ablation With 5-ALA","status":"NOT_YET_RECRUITING","sponsor":"Taoyuan General Hospital","startDate":"2024-12-01","conditions":"Lung Cancer - Non Small Cell, Lung Metastases From Any Primary","enrollment":6},{"nctId":"NCT05060237","phase":"PHASE1","title":"Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2021-12-01","conditions":"Actinic Keratosis, Keratosis, Actinic, Keratosis","enrollment":112},{"nctId":"NCT04618276","phase":"NA","title":"Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-II)","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2021-01-15","conditions":"Postoperative Wound Infection Deep Incisional Surgical Site, Prosthesis and Implants, Surgical Site Infection","enrollment":20},{"nctId":"NCT06507644","phase":"NA","title":"Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment","status":"NOT_YET_RECRUITING","sponsor":"University of Nove de Julho","startDate":"2024-11-30","conditions":"Actinic Keratoses","enrollment":144},{"nctId":"NCT05600322","phase":"PHASE3","title":"Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer","status":"COMPLETED","sponsor":"Photocure","startDate":"2022-11-03","conditions":"Bladder Cancer","enrollment":158},{"nctId":"NCT05123534","phase":"PHASE2","title":"A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG","status":"SUSPENDED","sponsor":"SonALAsense, Inc.","startDate":"2022-08-12","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma","enrollment":15},{"nctId":"NCT06577311","phase":"PHASE2","title":"Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)","status":"RECRUITING","sponsor":"The Center for Clinical and Cosmetic Research","startDate":"2024-08-14","conditions":"Cutaneous Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT00469417","phase":"PHASE3","title":"Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"1999-10-18","conditions":"Superficial Basal Cell Carcinoma","enrollment":120},{"nctId":"NCT06252727","phase":"PHASE1","title":"Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)","status":"WITHDRAWN","sponsor":"University of California, Davis","startDate":"2024-07","conditions":"Soft Tissue Sarcoma, Soft Tissue Sarcoma Adult","enrollment":""},{"nctId":"NCT06548438","phase":"PHASE4","title":"The Impact of PDD During TURB for NMIBC","status":"NOT_YET_RECRUITING","sponsor":"A.O.U. Città della Salute e della Scienza","startDate":"2024-09-01","conditions":"Bladder Cancer","enrollment":300},{"nctId":"NCT06545396","phase":"NA","title":"Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2024-08","conditions":"Actinic Keratoses","enrollment":20},{"nctId":"NCT00472043","phase":"PHASE3","title":"PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2000-10-01","conditions":"Basal Cell Carcinoma","enrollment":66},{"nctId":"NCT06466031","phase":"NA","title":"Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme","status":"NOT_YET_RECRUITING","sponsor":"Copernicus Memorial Hospital","startDate":"2024-09-01","conditions":"Glioblastoma Multiforme","enrollment":189},{"nctId":"NCT03963102","phase":"PHASE4","title":"Duration of Ameluz Application in Acral Actinic Keratoses Response","status":"TERMINATED","sponsor":"Royal Cornwall Hospitals Trust","startDate":"2019-10-30","conditions":"Actinic Keratoses, Photodamaged Skin","enrollment":28},{"nctId":"NCT05370508","phase":"PHASE1, PHASE2","title":"A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM","status":"TERMINATED","sponsor":"SonALAsense, Inc.","startDate":"2023-02-06","conditions":"Recurrent GBM","enrollment":8},{"nctId":"NCT03327831","phase":"PHASE4","title":"Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2015-04","conditions":"Actinic Keratosis","enrollment":30},{"nctId":"NCT04305470","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma","status":"COMPLETED","sponsor":"NX Development Corp","startDate":"2020-10-28","conditions":"Meningioma","enrollment":108},{"nctId":"NCT00437320","phase":"PHASE2","title":"Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-04-18","conditions":"Photoaged Skin","enrollment":32},{"nctId":"NCT06418113","phase":"PHASE1","title":"Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma","status":"RECRUITING","sponsor":"Hospital San Carlos, Madrid","startDate":"2024-03-21","conditions":"Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype","enrollment":12},{"nctId":"NCT04626661","phase":"","title":"Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study)","status":"COMPLETED","sponsor":"Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research","startDate":"2020-06-15","conditions":"Mitochondrial Oxygenation Measurement, Measurement Error, Healthy","enrollment":33},{"nctId":"NCT04556929","phase":"NA","title":"Enhanced Detection in Glioma Excision","status":"TERMINATED","sponsor":"University of Oxford","startDate":"2020-09-21","conditions":"Glioma","enrollment":4},{"nctId":"NCT03110159","phase":"PHASE1, PHASE2","title":"DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients","status":"COMPLETED","sponsor":"Medical Dermatology Specialists","startDate":"2017-08-29","conditions":"Skin Cancer, Non-melanoma Skin Cancer, Sun Damaged Skin","enrollment":8},{"nctId":"NCT05725213","phase":"","title":"ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis","status":"COMPLETED","sponsor":"Galderma Laboratorium GmbH","startDate":"2022-11-01","conditions":"Actinic Keratoses","enrollment":224}],"_emaApprovals":[],"_faersSignals":[{"count":68,"reaction":"OFF LABEL USE"},{"count":52,"reaction":"APPLICATION SITE PAIN"},{"count":48,"reaction":"APPLICATION SITE ERYTHEMA"},{"count":17,"reaction":"DRUG INEFFECTIVE"},{"count":15,"reaction":"APPLICATION SITE SWELLING"},{"count":10,"reaction":"APPLICATION SITE PUSTULES"},{"count":10,"reaction":"ERYTHEMA"},{"count":10,"reaction":"HYPERSENSITIVITY"},{"count":10,"reaction":"PAIN"},{"count":9,"reaction":"PRODUCT COLOUR ISSUE"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20160510","type":"ORIG","sponsor":"BIOFRONTERA","applicationNumber":"NDA208081"},{"date":"20170906","type":"SUPPL","sponsor":"BIOFRONTERA","applicationNumber":"NDA208081"},{"date":"20241004","type":"SUPPL","sponsor":"BIOFRONTERA","applicationNumber":"NDA208081"},{"date":"20240311","type":"SUPPL","sponsor":"BIOFRONTERA","applicationNumber":"NDA208081"},{"date":"20210525","type":"SUPPL","sponsor":"BIOFRONTERA","applicationNumber":"NDA208081"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":19,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Ameluz","genericName":"Ameluz","companyName":"Sherrif Ibrahim","companyId":"sherrif-ibrahim","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}